Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Synchrotron X-ray microtransections: a non invasive approach for epileptic seizures arising from eloquent cortical areas.
Validation of the Oxford Participation and Activities Questionnaire.
The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination.
Investigation of cerebral microbleeds in multiple sclerosis as a potential marker of blood-brain barrier dysfunction.
Diffusion tensor imaging and functional MRI.
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod.
Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responses.
Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space.
Stem cell treatment for multiple sclerosis.
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.
Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.
Follow-up of hypertension in patients with multiple sclerosis.
Imaging as an Outcome Measure in Multiple Sclerosis.
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective.
The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels.
[A treatment of neuromyelitis optica (Devic's disease) during pregnancy].
Effect of long-term weightlessness on retina and optic nerve in tail-suspension rats.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Enterovirus infections in Singaporean children: an assessment of neurological manifestations and clinical outcomes.
Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
Peptidyl Aldehyde Specifically Interacts with Immunosubunit β1i Proteasome: In Vitro and In Vivo Effects.
Pages
« first
‹ previous
…
753
754
755
756
757
758
759
760
761
…
next ›
last »